Alpha 2.0
Login Register
» Journals » Clin Positron Imaging

Clinical Positron Imaging : Official Journal of the Institute for Clinical P.e.t

Clinical Positron Imaging : Official Journal of the Institute for Clinical P.e.t is a scientific journal, published since 1998 in English. The journal's country of origin is United States.
Details
Abbr. Clin Positron Imaging
Start 1998
End 2000
Frequency Bimonthly, 1999-2000
p-ISSN 1095-0397
Country United States
Language English
Recent Articles
1.
Changes in FDG Tumor Uptake during and after Fractionated Radiation Therapy in a Rodent Tumor Xenograft
Humm J, Lee J, ODonoghue J, Squire O, Ling C, Pentlow K, et al.
Clin Positron Imaging . 2003 Oct; 2(5):289-296. PMID: 14516653
OBJECTIVE: The uptake of FDG was measured before, during, and after fractionated radiation in order to evaluate the potential of FDG-PET imaging as an indicator of tumor response.METHODS: The study...
2.
Diabetes Decreases FDG Accumulation in Primary Lung Cancer
Torizuka T, Zasadny K, Wahl R
Clin Positron Imaging . 2003 Oct; 2(5):281-287. PMID: 14516652
OBJECTIVE: To compare kinetics and accumulation of 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) in primary lung cancer between diabetic and non-diabetic patients using positron emission tomography (PET).METHODS: Five diabetic patients and 21 non-diabetic patients...
3.
Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET
Kim S, Chung J, Kim B, Kim S, Jeong J, Lee D, et al.
Clin Positron Imaging . 2003 Oct; 2(5):273-279. PMID: 14516651
The pattern and intensity of F-18-FDG uptake in the gastrointestinal (GI) tract are variable and can often cause confusion. The purpose of this study was to evaluate the relationship between...
4.
Utility of PET in Breast Cancer
Avril N, Schelling M, Dose J, Weber W, Schwaiger M
Clin Positron Imaging . 2003 Oct; 2(5):261-271. PMID: 14516650
Breast cancer represents the most frequent malignant disease in women and the second leading cause of cancer death in western countries. Current available treatment includes surgery, radiation therapy, chemotherapy, and...
5.
FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography
Yeung H, Macapinlac H, Mazumdar M, Bains M, Finn R, Larson S
Clin Positron Imaging . 2003 Oct; 2(5):255-260. PMID: 14516649
OBJECTIVES: To evaluate the clinical utility of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with cancer (CA) of the esophagus, and its incremental value over computed tomography (CT) scan.METHODS: Positron...
6.
Electronic Generators for the Production of Positron-Emitter Labeled Radiopharmaceuticals. Where Would PET Be Without Them?
Satyamurthy N, Phelps M, Barrio J
Clin Positron Imaging . 2003 Oct; 2(5):233-253. PMID: 14516648
The emergence of clinical positron emission tomography (PET) has enabled a routine and noninvasive assessment of cancer, neurological disorders, and coronary artery disease in humans. Vital to a sustained growth...
7.
Detection of Vasculitis by FDG-PET Using MCD
Erler H, Gruber J, Riccabona G, Moncayo R
Clin Positron Imaging . 2003 Oct; 2(6):350. PMID: 14516647
No abstract available.
8.
The Clinical Impact of FDG-PET Imaging on the Management of Lung Cancer Patients in a New Canadian PET Center
Boucher L, Benard F
Clin Positron Imaging . 2003 Oct; 2(6):349. PMID: 14516646
No abstract available.
9.
A Coordinate System for Lesion Mapping and Distribution in Progressive Prostate Cancer Using Positron Emission Tomography (PET)
Srivastava N, Erdi Y, Divgi C, Scher H, Larson S
Clin Positron Imaging . 2003 Oct; 2(6):348. PMID: 14516645
No abstract available.
10.
The Impact of F-18-FDG PET on the Management and Survival of Patients with Primary and Suspected Recurrent Colorectal Cancer
Vomocil B, Hanna W, Bell J, Hunter K, Hubner K
Clin Positron Imaging . 2003 Oct; 2(6):347. PMID: 14516644
No abstract available.